Testing effectiveness (Phase 2)Study completedNCT04063124
What this trial is testing
Senolytic Therapy to Modulate Progression of Alzheimer's Disease
Who this might be right for
Alzheimer Disease
The University of Texas Health Science Center at San Antonio 5